Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The adrenergic alpha 1 (α1) receptor is a G protein-coupled receptor that mediates the effects of norepinephrine and epinephrine. It has three subtypes (α1A, α1B, α1D) and is primarily responsible for vasoconstriction, smooth muscle contraction, and modulation of neurotransmission. Activation of α1 receptors leads to increased intracellular calcium levels through the Gq/11-PLC-IP3/DAG pathway. α1 agonists are used to treat hypotension, while antagonists are used to treat hypertension and benign prostatic hyperplasia.
Agonists activate the receptor, leading to Gq/11 protein activation, PLC stimulation, IP3/DAG production, and increased intracellular calcium levels. Antagonists block the receptor, preventing catecholamine-induced activation and downstream signaling.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adrenergic Alpha 1 Receptor (α₁).